Regulus Therapeutics Inc. (NASDAQ: RGLS)
$1.4000
-0.0900 ( -4.76% ) 168.0K
Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development.
Market Data
Open
$1.4000
Previous close
$1.4900
Volume
168.0K
Market cap
$92.36M
Day range
$1.3700 - $1.5650
52 week range
$1.0800 - $3.7900
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | May 17, 2024 |
| 8-k | 8K-related | 14 | May 17, 2024 |
| 4 | Insider transactions | 1 | May 17, 2024 |
| 4 | Insider transactions | 1 | May 17, 2024 |
| 4 | Insider transactions | 1 | May 17, 2024 |
| 4 | Insider transactions | 1 | May 17, 2024 |
| 4 | Insider transactions | 1 | May 17, 2024 |
| 4 | Insider transactions | 1 | May 17, 2024 |
| 8-k | 8K-related | 15 | May 09, 2024 |
| 10-q | Quarterly Reports | 52 | May 09, 2024 |